Goodbye to hypos? 9 December 2014 Could hypoglycaemia soon be a thing of the past? A young scientist in the US has developed a non-insulin drug for people with type two diabetes that could help eliminate the risk of low-blood glucose hypos. Some people with type two diabetes use insulin to keep their blood glucose levels in check. If blood-glucose levels become too low, hypoglycaemia can occur and this can be life-threatening. To combat this, Arnab De, a scientist with a PhD in microbiology and immunology at Columbia University, developed a non-insulin drug in collaboration with fellow scientist Richard DiMarchi of Indiana University. “We find that there is a peptide hormone in the gut called GLP1 that increases the secretion of insulin only when the blood glucose is high,” Dr De said. “This effectively eliminates the risk of hypoglycemic shock. Another advantage is that GLP1 administration has been found to stimulate weight-loss. “The hormone offers the promise of revolutionising the treatment of type two diabetes and reduce obesity.” Read the article online at: http://www.diabetesqld.org.au/
Blog 30 July 2025 Stroke awareness and prevention Stroke awareness week runs from 31 August to 6 Sept 2020 Continue Reading
News 29 July 2025 Lower PBS medicine costs to benefit Australians living with diabetes Australians living with diabetes will save money from a further reduction in the cost of prescription medicines, with the Pharmaceutical... Continue Reading
News 23 July 2025 Ozempic supply returning to normal in Australia Diabetes Australia has welcomed confirmation that the supply of Ozempic (semaglutide) in Australia has stabilised, with prescribing and supply restrictions... Continue Reading